D2C7
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for D2C7, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: D2C7 for Adult Patients With Recurrent Malignant Glioma [Phase 1]